A 20-month-old boy is referred to a paediatric endocrine clinic for evaluation.
November 5, 2026
We are delighted to welcome you to the 12th Insights into MAnaging Growth for Endocrine nurses (IMAGE) November 2026 Meeting, organised by Springer Health+ IME. This event will be dedicated to the loving memory of Professor Martin Savage and will take place on 5–6 November 2026 in the beautiful and historic city of Seville in Spain.
Find out about the risks and management of endocrine adverse events in children and adolescents undergoing immune checkpoint therapy for cancer.
Testicular dysfunction after treatment for childhood haematological malignancy is “mostly reversible” but warrants long-term endocrine surveillance in survivors, Argentinian researchers say.
Temple syndrome (TS14) has a broader range of phenotypic features than previously recognised and the presentation may change with increasing age, indicates an analysis of children attending two European referral centres.
Islet autoantibody screening for early-stage type 1 diabetes in children is feasible in the general population, the Fr1da study investigators have found.
VIDEO INTERVIEWS
Join Professor Martin Savage and expert colleagues for this series of interviews as they explore different perspectives and insights into how to successfully implement precision medicine into the management of paediatric endocrine disorders.
Open Access Article Now Available
Digital technologies to improve the precision of paediatric growth disorder diagnosis and management
View the article published in the Growth Hormone & IGF Research journal that summarises the webinar discussion on the role of digital health in growth disorders.
